A genetically engineered mouse model targeting the initiating driver mutations of TP53 and CCNE1 in the LGR-expressing cancer initiation cells in FTE will be an ideal model to test the effect of ovulation on the genesis and metastasis of HGSC. The gene discussed is TP53; the disease is cancer.